Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering

[Display omitted] •Two cocrystals of xanthotoxin were obtained. Crystal structures of the two cocrystals were elucidated.•Energy framework calculation was performed to confirm hydrogen bond and π···π interactions generated in cocrystals are stronger than that in xanthotoxin.•Superior solubility and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of pharmaceutics 2019-12, Vol.572, p.118776-118776, Article 118776
Hauptverfasser: Chen, Jin-Yao, Wu, Hao, Guo, Chun-Yang, Zhu, Bin, Ren, Guo-Bin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 118776
container_issue
container_start_page 118776
container_title International journal of pharmaceutics
container_volume 572
creator Chen, Jin-Yao
Wu, Hao
Guo, Chun-Yang
Zhu, Bin
Ren, Guo-Bin
description [Display omitted] •Two cocrystals of xanthotoxin were obtained. Crystal structures of the two cocrystals were elucidated.•Energy framework calculation was performed to confirm hydrogen bond and π···π interactions generated in cocrystals are stronger than that in xanthotoxin.•Superior solubility and stability of xanthotoxin-oxalic acid cocrystal were demonstrated. The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability. A comprehensive cocrystal study for the insoluble natural pharmaceutical compound xanthotoxin (XT) was conducted, in which xanthotoxin-para aminobenzoic acid (XT-PABA) and xanthotoxin-oxalic acid (XT-OA) cocrystals were obtained. The xanthotoxin cocrystals were characterized by powder X-ray diffraction, thermal analysis, and FT-IR spectra, and the crystal structures were determined by single-crystal X-ray diffraction. Crystal structures and thermal analysis showed that XT-OA was more stable than XT-PABA. Energy framework calculation indicated that H-bond and π···π interactions generated in XT-OA were stronger than that in XT-PABA and xanthotoxin. The powder dissolution experiments of xanthotoxin and its cocrystals suggested the XT-OA cocrystal might be applied as an alternative formulation of API, on account of its enhanced solubility and stability in the hydrochloric acid buffer solution (pH 1.2). The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability.
doi_str_mv 10.1016/j.ijpharm.2019.118776
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2311926306</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037851731930821X</els_id><sourcerecordid>2311926306</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-78e2a8559e085ce38c7bb9c123941463487dfa91aa92b8087d028057f50bd3233</originalsourceid><addsrcrecordid>eNqFkE1v3CAQhlGVqtmk_QmNOObiLR824FNVRWkbKVIv7RlhPM6ywrABHGXz68Nqt7nmNBrmeRjNi9BXStaUUPFtu3bb3cakec0I7deUKinFB7SqlTe8leIMrQiXqumo5OfoIuctIUQwyj-hc06FVFy2K5Ruw8YE68IDLhvAOfplcN6VPY4TDqYsyXhs47yLSxjxswllE0t8dgEPezzHcfGmHORczMl7cqYKNu3rk_fupc5jwBAeXABIlf2MPk7GZ_hyqpfo38_bvze_m_s_v-5uftw3louuNFIBM6rreiCqs8CVlcPQW8p439JW8FbJcTI9NaZngyK1I0yRTk4dGUbOOL9E18d_dyk-LpCLnl224L0JEJesGae0Z4ITUdHuiNoUc04w6V1ys0l7TYk-xK23-hS3PsStj3FX7-q0YhlmGN-s__lW4PsRgHrok4Oks3UQLIwugS16jO6dFa8fOJYr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2311926306</pqid></control><display><type>article</type><title>Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Chen, Jin-Yao ; Wu, Hao ; Guo, Chun-Yang ; Zhu, Bin ; Ren, Guo-Bin</creator><creatorcontrib>Chen, Jin-Yao ; Wu, Hao ; Guo, Chun-Yang ; Zhu, Bin ; Ren, Guo-Bin</creatorcontrib><description>[Display omitted] •Two cocrystals of xanthotoxin were obtained. Crystal structures of the two cocrystals were elucidated.•Energy framework calculation was performed to confirm hydrogen bond and π···π interactions generated in cocrystals are stronger than that in xanthotoxin.•Superior solubility and stability of xanthotoxin-oxalic acid cocrystal were demonstrated. The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability. A comprehensive cocrystal study for the insoluble natural pharmaceutical compound xanthotoxin (XT) was conducted, in which xanthotoxin-para aminobenzoic acid (XT-PABA) and xanthotoxin-oxalic acid (XT-OA) cocrystals were obtained. The xanthotoxin cocrystals were characterized by powder X-ray diffraction, thermal analysis, and FT-IR spectra, and the crystal structures were determined by single-crystal X-ray diffraction. Crystal structures and thermal analysis showed that XT-OA was more stable than XT-PABA. Energy framework calculation indicated that H-bond and π···π interactions generated in XT-OA were stronger than that in XT-PABA and xanthotoxin. The powder dissolution experiments of xanthotoxin and its cocrystals suggested the XT-OA cocrystal might be applied as an alternative formulation of API, on account of its enhanced solubility and stability in the hydrochloric acid buffer solution (pH 1.2). The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2019.118776</identifier><identifier>PMID: 31678374</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>4-Aminobenzoic Acid - chemistry ; Cocrystals ; Crystal structure ; Crystallization - methods ; Crystallography, X-Ray - methods ; Drug Stability ; Hydrogen Bonding ; Methoxsalen - chemistry ; Oxalic Acid - chemistry ; Powder Diffraction - methods ; Powders - chemistry ; Solubility ; Solubility - drug effects ; Stability ; X-Ray Diffraction - methods ; Xanthotoxin</subject><ispartof>International journal of pharmaceutics, 2019-12, Vol.572, p.118776-118776, Article 118776</ispartof><rights>2019 Elsevier B.V.</rights><rights>Copyright © 2019 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-78e2a8559e085ce38c7bb9c123941463487dfa91aa92b8087d028057f50bd3233</citedby><cites>FETCH-LOGICAL-c365t-78e2a8559e085ce38c7bb9c123941463487dfa91aa92b8087d028057f50bd3233</cites><orcidid>0000-0003-1085-1231</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2019.118776$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31678374$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Jin-Yao</creatorcontrib><creatorcontrib>Wu, Hao</creatorcontrib><creatorcontrib>Guo, Chun-Yang</creatorcontrib><creatorcontrib>Zhu, Bin</creatorcontrib><creatorcontrib>Ren, Guo-Bin</creatorcontrib><title>Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>[Display omitted] •Two cocrystals of xanthotoxin were obtained. Crystal structures of the two cocrystals were elucidated.•Energy framework calculation was performed to confirm hydrogen bond and π···π interactions generated in cocrystals are stronger than that in xanthotoxin.•Superior solubility and stability of xanthotoxin-oxalic acid cocrystal were demonstrated. The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability. A comprehensive cocrystal study for the insoluble natural pharmaceutical compound xanthotoxin (XT) was conducted, in which xanthotoxin-para aminobenzoic acid (XT-PABA) and xanthotoxin-oxalic acid (XT-OA) cocrystals were obtained. The xanthotoxin cocrystals were characterized by powder X-ray diffraction, thermal analysis, and FT-IR spectra, and the crystal structures were determined by single-crystal X-ray diffraction. Crystal structures and thermal analysis showed that XT-OA was more stable than XT-PABA. Energy framework calculation indicated that H-bond and π···π interactions generated in XT-OA were stronger than that in XT-PABA and xanthotoxin. The powder dissolution experiments of xanthotoxin and its cocrystals suggested the XT-OA cocrystal might be applied as an alternative formulation of API, on account of its enhanced solubility and stability in the hydrochloric acid buffer solution (pH 1.2). The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability.</description><subject>4-Aminobenzoic Acid - chemistry</subject><subject>Cocrystals</subject><subject>Crystal structure</subject><subject>Crystallization - methods</subject><subject>Crystallography, X-Ray - methods</subject><subject>Drug Stability</subject><subject>Hydrogen Bonding</subject><subject>Methoxsalen - chemistry</subject><subject>Oxalic Acid - chemistry</subject><subject>Powder Diffraction - methods</subject><subject>Powders - chemistry</subject><subject>Solubility</subject><subject>Solubility - drug effects</subject><subject>Stability</subject><subject>X-Ray Diffraction - methods</subject><subject>Xanthotoxin</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1v3CAQhlGVqtmk_QmNOObiLR824FNVRWkbKVIv7RlhPM6ywrABHGXz68Nqt7nmNBrmeRjNi9BXStaUUPFtu3bb3cakec0I7deUKinFB7SqlTe8leIMrQiXqumo5OfoIuctIUQwyj-hc06FVFy2K5Ruw8YE68IDLhvAOfplcN6VPY4TDqYsyXhs47yLSxjxswllE0t8dgEPezzHcfGmHORczMl7cqYKNu3rk_fupc5jwBAeXABIlf2MPk7GZ_hyqpfo38_bvze_m_s_v-5uftw3louuNFIBM6rreiCqs8CVlcPQW8p439JW8FbJcTI9NaZngyK1I0yRTk4dGUbOOL9E18d_dyk-LpCLnl224L0JEJesGae0Z4ITUdHuiNoUc04w6V1ys0l7TYk-xK23-hS3PsStj3FX7-q0YhlmGN-s__lW4PsRgHrok4Oks3UQLIwugS16jO6dFa8fOJYr</recordid><startdate>20191215</startdate><enddate>20191215</enddate><creator>Chen, Jin-Yao</creator><creator>Wu, Hao</creator><creator>Guo, Chun-Yang</creator><creator>Zhu, Bin</creator><creator>Ren, Guo-Bin</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1085-1231</orcidid></search><sort><creationdate>20191215</creationdate><title>Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering</title><author>Chen, Jin-Yao ; Wu, Hao ; Guo, Chun-Yang ; Zhu, Bin ; Ren, Guo-Bin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-78e2a8559e085ce38c7bb9c123941463487dfa91aa92b8087d028057f50bd3233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>4-Aminobenzoic Acid - chemistry</topic><topic>Cocrystals</topic><topic>Crystal structure</topic><topic>Crystallization - methods</topic><topic>Crystallography, X-Ray - methods</topic><topic>Drug Stability</topic><topic>Hydrogen Bonding</topic><topic>Methoxsalen - chemistry</topic><topic>Oxalic Acid - chemistry</topic><topic>Powder Diffraction - methods</topic><topic>Powders - chemistry</topic><topic>Solubility</topic><topic>Solubility - drug effects</topic><topic>Stability</topic><topic>X-Ray Diffraction - methods</topic><topic>Xanthotoxin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Jin-Yao</creatorcontrib><creatorcontrib>Wu, Hao</creatorcontrib><creatorcontrib>Guo, Chun-Yang</creatorcontrib><creatorcontrib>Zhu, Bin</creatorcontrib><creatorcontrib>Ren, Guo-Bin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Jin-Yao</au><au>Wu, Hao</au><au>Guo, Chun-Yang</au><au>Zhu, Bin</au><au>Ren, Guo-Bin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2019-12-15</date><risdate>2019</risdate><volume>572</volume><spage>118776</spage><epage>118776</epage><pages>118776-118776</pages><artnum>118776</artnum><issn>0378-5173</issn><eissn>1873-3476</eissn><abstract>[Display omitted] •Two cocrystals of xanthotoxin were obtained. Crystal structures of the two cocrystals were elucidated.•Energy framework calculation was performed to confirm hydrogen bond and π···π interactions generated in cocrystals are stronger than that in xanthotoxin.•Superior solubility and stability of xanthotoxin-oxalic acid cocrystal were demonstrated. The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability. A comprehensive cocrystal study for the insoluble natural pharmaceutical compound xanthotoxin (XT) was conducted, in which xanthotoxin-para aminobenzoic acid (XT-PABA) and xanthotoxin-oxalic acid (XT-OA) cocrystals were obtained. The xanthotoxin cocrystals were characterized by powder X-ray diffraction, thermal analysis, and FT-IR spectra, and the crystal structures were determined by single-crystal X-ray diffraction. Crystal structures and thermal analysis showed that XT-OA was more stable than XT-PABA. Energy framework calculation indicated that H-bond and π···π interactions generated in XT-OA were stronger than that in XT-PABA and xanthotoxin. The powder dissolution experiments of xanthotoxin and its cocrystals suggested the XT-OA cocrystal might be applied as an alternative formulation of API, on account of its enhanced solubility and stability in the hydrochloric acid buffer solution (pH 1.2). The cocrystallization engineering can prolong the enhanced apparent solubility via modulating the stability.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>31678374</pmid><doi>10.1016/j.ijpharm.2019.118776</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1085-1231</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0378-5173
ispartof International journal of pharmaceutics, 2019-12, Vol.572, p.118776-118776, Article 118776
issn 0378-5173
1873-3476
language eng
recordid cdi_proquest_miscellaneous_2311926306
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects 4-Aminobenzoic Acid - chemistry
Cocrystals
Crystal structure
Crystallization - methods
Crystallography, X-Ray - methods
Drug Stability
Hydrogen Bonding
Methoxsalen - chemistry
Oxalic Acid - chemistry
Powder Diffraction - methods
Powders - chemistry
Solubility
Solubility - drug effects
Stability
X-Ray Diffraction - methods
Xanthotoxin
title Enhancing the solubility of natural compound xanthotoxin by modulating stability via cocrystallization engineering
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T19%3A39%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enhancing%20the%20solubility%20of%20natural%20compound%20xanthotoxin%20by%20modulating%20stability%20via%20cocrystallization%20engineering&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Chen,%20Jin-Yao&rft.date=2019-12-15&rft.volume=572&rft.spage=118776&rft.epage=118776&rft.pages=118776-118776&rft.artnum=118776&rft.issn=0378-5173&rft.eissn=1873-3476&rft_id=info:doi/10.1016/j.ijpharm.2019.118776&rft_dat=%3Cproquest_cross%3E2311926306%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2311926306&rft_id=info:pmid/31678374&rft_els_id=S037851731930821X&rfr_iscdi=true